Key Points Required minimum distributions are unavoidable once you reach 73. You can spend your RMD cash on yourself, invest it, or give it away to others. The $23,760 Social Security bonus most retirees completely overlook › You have to take required minimum distributions (RMDs) from individual retirement accounts and 401(k) accounts when you hit 73. RMDs can create tax complications that you may...
Key Points Required minimum distributions are unavoidable once you reach 73. You can spend your RMD cash on yourself, invest it, or give it away to others. The $23,760 Social Security bonus most retirees completely overlook › You have to take required minimum distributions (RMDs) from individual retirement accounts and 401(k) accounts when you hit 73. RMDs can create tax complications that you may not be expecting because they count as income. Moreover, they can play havoc with other benefits, like increasing the Medicare premiums you pay. So what do you do with the money if you don't need it? Here are a few possibilities. 1. Keep the RMDs for your own use While you may not need your RMDs, that doesn't mean you can't use the money. For starters, you can use the cash to cover higher costs that may come with RMDs (like taxes and increased Medicare premiums). With any money that's left over, well, you can treat yourself. Maybe there's a trip you wouldn't have otherwise taken or a nice piece of jewelry you had your eye on for yourself or your spouse. You could even just go out to eat a little more often. It's your money; you earned the right to spend it in whatever manner brings you the most joy. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » 2. Invest your RMD You might decide that spending money just to spend money feels wrong. If that's the case, you can simply put the cash into a taxable investment account and reinvest it. You might even decide to repurchase whatever you sold from your retirement account to fund the RMD. Just because you have to take an RMD doesn't mean you have to stop investing. 3. Use your RMD for gifts If you don't want to use your RMD to spend on yourself and you aren't going to invest the money, you could give that cash to other people. The most obvious choice is to simply ...
Futures dipped as U.S. oil prices hit $100 while Micron fell despite blowout earnings. The Dow Jones and S&P 500 undercut recent lows on cautious Powell comments.
Futures dipped as U.S. oil prices hit $100 while Micron fell despite blowout earnings. The Dow Jones and S&P 500 undercut recent lows on cautious Powell comments.
Relativity , a legal data firm backed by Silver Lake , has picked banks to help arrange for an initial public offering, according to people familiar with the matter. The Chicago-based company is working with Goldman Sachs Group Inc. , JPMorgan Chase & Co. , and Barclays Plc targeting a first-time share sale that would value the company at around $4 billion and that could take place as soon as the ...
Relativity , a legal data firm backed by Silver Lake , has picked banks to help arrange for an initial public offering, according to people familiar with the matter. The Chicago-based company is working with Goldman Sachs Group Inc. , JPMorgan Chase & Co. , and Barclays Plc targeting a first-time share sale that would value the company at around $4 billion and that could take place as soon as the first half of this year, the people said. An IPO could raise about $750 million, one of the people said. Relativity’s potential IPO would come as uncertainty surrounding the risks of artificial intelligence is dividing the market into winners and losers, with shares of software firms sharply lower than where they entered the year. Read More: A Stock Market Doom Loop Is Hitting Everything That Touches AI Deliberations are ongoing and more banks may be added to the lineup, the people said, asking not to be identified because the information is not public. Representatives for Goldman Sachs, JPMorgan, Barclays and Silver Lake declined to comment. A spokesperson for Relativity didn’t immediately respond to requests for comment. Relativity has released a generative artificial intelligence-powered case intelligence product, according to a company statement in January. The tool seeks to make developing case narratives faster and simpler for lawyers and litigation professionals. Silver Lake made an investment in the company in March 2021 at a roughly $3.6 billion valuation, according to PitchBook data. For the latest news on equity capital markets activity in the US, Canada and Latin America, follow the channel or visit NI BFWECMUS . To subscribe to ECM Watch , Bloomberg’s daily roundup of news from around the region, click here . Founded in 2001, Relativity has more than 1,600 employees around the world, according to its website. The company’s flagship product is RelativityOne, a cloud-based platform that allows legal professionals to manage and analyze large datasets.
Good morning . Fed holds rates steady as Powell signals he won’t step aside. Tehran warns Gulf assets are now legitimate targets. And Netflix is turning its top hit into a global concert tour. Listen to the day’s top stories . Market Snapshot S&P 500 6,624.70 -1.4% Bloomberg Dollar Spot Index 1,213.75 +0.5% WTI Crude Oil Futures $96.32 +0.1% Market data as of 05:31 PM ET. Data is subject to provid...
Good morning . Fed holds rates steady as Powell signals he won’t step aside. Tehran warns Gulf assets are now legitimate targets. And Netflix is turning its top hit into a global concert tour. Listen to the day’s top stories . Market Snapshot S&P 500 6,624.70 -1.4% Bloomberg Dollar Spot Index 1,213.75 +0.5% WTI Crude Oil Futures $96.32 +0.1% Market data as of 05:31 PM ET. Data is subject to provider delays. Federal Reserve officials kept interest rates unchanged and maintained their forecast for one cut this year amid heightened uncertainty due to war in the Middle East. Chair Jerome Powell emphasized that further reductions would require progress in lowering inflation, especially in goods prices affected by tariffs. At a press conference, he said he intends to remain at the central bank until the Justice Department’s investigation is over. Tehran warned that a number of Gulf assets are now “ legitimate targets ” after Israel attacked Iran’s South Pars gas field. Qatar’s Ras Laffan Industrial City suffered “extensive damage” after an Iranian missile strike. Donald Trump temporarily waived a century-old shipping mandate to lower the cost of transporting energy goods around the US. Saudi Arabia ramped up oil exports to more than half of normal levels despite disruptions from the war, using a pipeline to bypass the Strait of Hormuz. India is deploying over half a dozen warships to the Gulf of Oman and Arabian Sea to escort its fuel vessels. Courts in London and Dubai have issued a worldwide asset freeze against Paresh Raja, owner of Market Financial Solutions. The UK firm, which collapsed in February amid misconduct allegations, had borrowed over £2 billion from Wall Street lenders including Barclays and Apollo’s Atlas SP. Creditors face potential losses of at least £1.3 billion . Geely Eyes Canadian Auto Market After Deal Allowing Chinese EVs Read more Tencent will double AI investments to more than 36 billion yuan ($5.2 billion) in 2026, funded by reducing share buyb...
Beijing’s global pharmaceutical push is following a playbook seen in rare earths, semiconductors and electric vehicles, US lawmakers said on Wednesday, as concerns grow over the United States’ reliance on Chinese drug ingredients. “China is cornering the market on our medicines – from the supply of generic drugs that Americans depend on every day, to the cutting-edge biotech pipeline that will det...
Beijing’s global pharmaceutical push is following a playbook seen in rare earths, semiconductors and electric vehicles, US lawmakers said on Wednesday, as concerns grow over the United States’ reliance on Chinese drug ingredients. “China is cornering the market on our medicines – from the supply of generic drugs that Americans depend on every day, to the cutting-edge biotech pipeline that will determine who leads medicine in the years and decades ahead,” said John Moolenaar, the chair of the House Select Committee on China The hearing, titled “From the Science Lab to the Medicine Cabinet: How China is Cornering the Market on Our Medicines,” examined the United States’ growing supply chain dependence on China’s pharmaceutical industry. Advertisement Florida Republican Neal Dunn on Wednesday accused China of executing a deliberate, long-term strategy to move up the pharmaceutical value chain. “They’ve done this with rare earths solar energy , batteries, electric vehicles , all these critical sectors they dominate and they subsidise,” he told the hearing, adding, “they move up the supply chain until they own the whole stack of the supply chain”. 08:58 What are rare earths, and why is China’s dominance facing global pushback What are rare earths, and why is China’s dominance facing global pushback China’s ageing population and global expansion are behind projections that the pharmaceutical industry’s revenue would rise by 50 per cent between 2024 and 2030. According to UBS estimates, the country’s drug and medical device businesses were forecast to generate more than US$2.1 trillion in revenue by 2030.
Micron Technology Inc. warned that it will need to spend heavily on production to meet burgeoning demand, overshadowing a generally upbeat forecast from the largest US maker of computer memory chips. Capital spending will exceed $25 billion this fiscal year, which runs through August, the company said as part of its quarterly report on Wednesday. Analysts had estimated $22.4 billion. The heavy spe...
Micron Technology Inc. warned that it will need to spend heavily on production to meet burgeoning demand, overshadowing a generally upbeat forecast from the largest US maker of computer memory chips. Capital spending will exceed $25 billion this fiscal year, which runs through August, the company said as part of its quarterly report on Wednesday. Analysts had estimated $22.4 billion. The heavy spending reflects the cost of keeping up with an insatiable appetite for Micron’s memory chips, especially the high-bandwidth components used in artificial intelligence computing. Though Micron’s sales are expected to keep soaring, the latest report drew a chilly reception from investors. The shares fell about 2% in late trading. Hendi Susanto, a portfolio manager at Gabelli Funds, said he thinks Micron is in a good position structurally. (Source: Bloomberg)
jetcityimage/iStock Editorial via Getty Images Back in late January, I reiterated my Buy rating on General Mills, Inc. ( GIS ) as I believed there was too much gloom and doom priced into the stock. I cited a slowing of organic sales declines, a clear strategy for FY2026, and a cheap valuation as the reasons for my bullishness. As you can clearly see in the rating history chart below, this Buy rati...
jetcityimage/iStock Editorial via Getty Images Back in late January, I reiterated my Buy rating on General Mills, Inc. ( GIS ) as I believed there was too much gloom and doom priced into the stock. I cited a slowing of organic sales declines, a clear strategy for FY2026, and a cheap valuation as the reasons for my bullishness. As you can clearly see in the rating history chart below, this Buy rating hasn't worked out like I envisioned. With the company having reported their latest earnings just earlier this morning (Mar 18th), today I will take another look at their fundamentals to see if my bullish thesis was a mistake. Seeking Alpha Below, it is shown that Q3 was an undeniably weak quarter for General Mills as they missed key expectations. Weather disruptions had an impact on their business activity and margin contraction is another potential concern. However, despite this weakness, General Mills actually reiterated their FY2026 guidance and so the longer term trajectory of the business remains on track. With that being the case, the recent fresh lows for their valuation seems indicative of an irrational amount of fear in the stock right now. Therefore, I've decided to reiterate my Buy rating on General Mills. Sales Declines Accelerate General Mills Q3 Slides Let's start with a look at their top line numbers for clues on where business activity is currently. In their FY2026 Q3, General Mills generated net sales of $4.4 billion, down a quite concerning 8% YoY. Do note that this still beat expectations by around $10 million. This is an acceleration of net sales declines from the previous quarter's 7% drop and so the trajectory of the business doesn't seem all that favorable. You can see in the above chart that acquisitions and divestures had a notable impact and so organic net sales is a better reflection of core business activity. With both organic volume and organic price/mix being weak, General Mills saw organic net sales declines of 3% YoY. That is a notable acc...
The European Union may soon ban nudify apps after Elon Musk's chatbot Grok emerged as a prime example of the dangers of an AI platform failing to block outputs that sexualized images of real people, including children . In a joint press release , the European Parliament's Internal Market and Civil Liberties committees confirmed that lawmakers voted 101–9 (with 8 abstentions) to simplify the Artifi...
The European Union may soon ban nudify apps after Elon Musk's chatbot Grok emerged as a prime example of the dangers of an AI platform failing to block outputs that sexualized images of real people, including children . In a joint press release , the European Parliament's Internal Market and Civil Liberties committees confirmed that lawmakers voted 101–9 (with 8 abstentions) to simplify the Artificial Intelligence Act and "propose bans on AI 'nudifier' systems." The vote came after the European Commission concluded earlier this year that the AI Act does not prohibit "AI systems that generate child sexual abuse material (CSAM) or sexually explicit deepfake nudes." At that time, the Commission signaled that Parliament members were already proposing ways to amend the law to strengthen protections against such harmful content. Read full article Comments
Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Get Free Report)'s share price dropped 1.9% during trading on Wednesday . The stock traded as low as $339.34 and last traded at $339.5570. Approximately 12,473,613 shares traded hands during trading, a decline of 11% from the average daily volume of 13,999,359 shares. The stock had previously closed at $345.98. Get TSM alerts: Sign Up Tai...
Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Get Free Report)'s share price dropped 1.9% during trading on Wednesday . The stock traded as low as $339.34 and last traded at $339.5570. Approximately 12,473,613 shares traded hands during trading, a decline of 11% from the average daily volume of 13,999,359 shares. The stock had previously closed at $345.98. Get TSM alerts: Sign Up Taiwan Semiconductor Manufacturing News Roundup Here are the key news stories impacting Taiwan Semiconductor Manufacturing this week: Analysts Set New Price Targets TSM has been the subject of several recent analyst reports. TD Cowen upped their price target on Taiwan Semiconductor Manufacturing from $325.00 to $370.00 and gave the stock a "hold" rating in a research note on Friday, January 16th. Argus raised shares of Taiwan Semiconductor Manufacturing to a "strong-buy" rating in a report on Thursday, January 15th. Dbs Bank upgraded shares of Taiwan Semiconductor Manufacturing to a "moderate buy" rating in a research note on Friday, January 23rd. Zacks Research raised shares of Taiwan Semiconductor Manufacturing from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, February 3rd. Finally, Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Taiwan Semiconductor Manufacturing in a research report on Friday, January 2nd. Four investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $391.43. View Our Latest Research Report on TSM Taiwan Semiconductor Manufacturing Stock Performance The firm's 50 day moving average price is $347.73 and its 200-day moving average price is $307.99. The firm has a market cap of $1.76 trillion, a price-to-earnings ratio of 31.88, a P/E/G ratio of 0.93 and a beta of 1.29. The company has a debt-to-equity ratio of 0.17, a current ra...
Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Boa...
Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today announced corporate updates and financial results for the year ended December 31, 2025. “In 2025, we continued to advance MT-601, our lead Multi-Antigen Recognizing (MAR)-T cell therapy, and generated highly encouraging clinical data from our ongoing Phase 1 APOLLO study,” said Juan Vera, M.D., President and Chief Executive Officer of Marker Therapeutics. “Updated results reported last August demonstrated a 66% objective response rate in relapsed non-Hodgkin lymphoma, including durable complete responses, with a favorable safety profile across evaluated doses. During the year we also reported immunomonitoring data indicating that lymphodepletion enhances the expansion and persistence of MT-601, and we advanced the APOLLO study into dose expansion in patients with relapsed Diffuse Large B Cell Lymphoma (DLBCL). We anticipate providing a data update from the APOLLO study in the second quarter of 2026.” Dr. Vera continued, “Beyond lymphoma, we made important progress expanding our MAR-T platform across hematologic and solid tumors. Recent research from Baylor College of Medicine published in Nature Medicine in early 2026 showed promising results in pancreatic cancer using MAR-T cells and received national coverage on Good Morning America.” “Looking ahead, we expect continued clinical exe...
Micron Technology (NASDAQ:MU) manufactures DRAM, flash memory, and SSDs. The stock closed Wednesday at $461.73, essentially flat with a 0.01% gain, as coverage and analyst previews highlight its after-the-bell fiscal Q2 earnings report. It’s a key test of AI-driven memory demand and elevated valuation expectations. Trading volume reached 46.1 million shares, coming in about 30% above its three-mon...
Micron Technology (NASDAQ:MU) manufactures DRAM, flash memory, and SSDs. The stock closed Wednesday at $461.73, essentially flat with a 0.01% gain, as coverage and analyst previews highlight its after-the-bell fiscal Q2 earnings report. It’s a key test of AI-driven memory demand and elevated valuation expectations. Trading volume reached 46.1 million shares, coming in about 30% above its three-month average of 35.5 million shares. Micron Technology IPO'd in 1984 and has grown 32,647% since going public. The S&P 500 (SNPINDEX:^GSPC) fell 1.37% to 6,624, while the Nasdaq Composite (NASDAQINDEX:^IXIC) declined 1.46% to finish at 22,152. Within semiconductors, industry peers Western Digital (NASDAQ:WDC) closed at $304.9 (-2.84%) and Seagate Technology (NASDAQ:STX) finished at $406.77 (-3.40%) as investors reassess AI hardware momentum. Micron stock has soared this year as investors focus on skyrocketing AI-driven memory pricing. Tech sector investors monitoring earnings didn’t move Micron shares much during the session with expectations that quickly rising sales and earnings may already be priced into Micron stock . Continue reading
Kevin Dietsch/Getty Images News The Federal Reserve's Open Market Committee (“FOMC”) held interest rates steady in March, as expected. The current overnight rate of 3.5-3.75% stands. This decision comes amidst a series of “wait and see” decisions that were expected by the market and previously telegraphed by the Fed. It's clear that they will not lower rates further until they see more progress wi...
Kevin Dietsch/Getty Images News The Federal Reserve's Open Market Committee (“FOMC”) held interest rates steady in March, as expected. The current overnight rate of 3.5-3.75% stands. This decision comes amidst a series of “wait and see” decisions that were expected by the market and previously telegraphed by the Fed. It's clear that they will not lower rates further until they see more progress with inflation. Since they began lowering rates in September last year, unemployment has actually risen, and so the dual mandate that the Fed has to contend with is still very much causing them conflict. Data by YCharts The March 2026 FOMC Statement And Changes Every meeting, the FOMC puts out a statement, though they tend to start with the last one as a base. Here's the new FOMC statement compared to the last statement, with new text in red, removed text crossed through, and shared text in black. CNBC Most of the statement was unchanged, aside from some wording about the timing of unemployment and inclusion of the U.S.-Iran War, though no specifics are given apart from that it introduces uncertainty. The most significant change was Governor Waller, who was previously in contention for the chair position before former Governor Warsh was nominated, moving from dissenting to consensus on a hold. T That leaves Governor Miran as the lone dissenter again; he has argued for further cuts during cut cycles and cuts during hold cycles in every meeting he has attended. NYT Powell's Presser Was All About Uncertainty In his penultimate presser as Fed chair—although if Warsh or someone else is not confirmed by the Senate, Powell will stay on as chair pro tem, as is protocol—Powell seemed a bit looser than usual. He declined fewer questions and spoke with more conviction in general. Powell did make a statement on whether he will stay on the board or not. He said that while he is still unsure if he will stay on or retire from the Fed after he is done with his chair appointment (his position...
Image source: The Motley Fool. Wednesday, Mar. 18, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Sanjay Mehrotra Chief Financial Officer — Mark Murphy Need a quote from a Motley Fool analyst? Email pr@fool.com Takeaways Revenue -- $23.9 billion, up 75% sequentially and 196% year over year, marking the fourth consecutive quarterly record. -- $23.9 billion, up 75% sequentially and...
Image source: The Motley Fool. Wednesday, Mar. 18, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Sanjay Mehrotra Chief Financial Officer — Mark Murphy Need a quote from a Motley Fool analyst? Email pr@fool.com Takeaways Revenue -- $23.9 billion, up 75% sequentially and 196% year over year, marking the fourth consecutive quarterly record. -- $23.9 billion, up 75% sequentially and 196% year over year, marking the fourth consecutive quarterly record. DRAM revenue -- $18.8 billion, up 207% year over year and 74% sequentially, making up 79% of total company revenue. -- $18.8 billion, up 207% year over year and 74% sequentially, making up 79% of total company revenue. DRAM pricing -- Increased in the 65%-67% range sequentially, driven by tight industry supply and favorable mix; bit shipments up mid-single digits. -- Increased in the 65%-67% range sequentially, driven by tight industry supply and favorable mix; bit shipments up mid-single digits. NAND revenue -- $5.0 billion, up 169% year over year and 82% sequentially, accounting for 21% of total revenue; bit shipments up low single digits, with prices rising in the 75%-79% range. -- $5.0 billion, up 169% year over year and 82% sequentially, accounting for 21% of total revenue; bit shipments up low single digits, with prices rising in the 75%-79% range. Gross margin -- 75%, a company record, up 18 percentage points sequentially and nearly double from the prior year, attributed mainly to higher pricing. -- 75%, a company record, up 18 percentage points sequentially and nearly double from the prior year, attributed mainly to higher pricing. Operating margin -- 69%, reflecting an increase of 22 percentage points sequentially and 44 percentage points year over year. -- 69%, reflecting an increase of 22 percentage points sequentially and 44 percentage points year over year. Free cash flow -- $6.9 billion, a quarterly record and up 77% from the previous record quarter. -- $6.9 billion, a quarterly record and ...
"I'm still gobsmacked by the Fed's decision," Bob Michele, JPMorgan Asset Management's global head of fixed income, says about the Federal Reserve's decision to leave interest rates unchanged. (Source: Bloomberg)
"I'm still gobsmacked by the Fed's decision," Bob Michele, JPMorgan Asset Management's global head of fixed income, says about the Federal Reserve's decision to leave interest rates unchanged. (Source: Bloomberg)